Are these two progesterone shots equal? new study finds out

NCT ID NCT07495007

First seen Mar 29, 2026 · Last updated May 15, 2026 · Updated 3 times

Summary

This study tested whether a new progesterone injection (Prontogest) works the same as the standard FDA-approved injection in healthy postmenopausal women. Twenty-six women aged 40-70 received both injections at different times, and researchers measured drug levels in the blood. The goal was to confirm the new version is bioequivalent, meaning it delivers the same amount of medicine.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIOEQUIVALANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Zi Diligence Biocenter

    Cairo, Cairo Governorate, 19653, Egypt

Conditions

Explore the condition pages connected to this study.